Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma

Leuk Lymphoma. 2007 Jun;48(6):1216-8. doi: 10.1080/10428190701344907.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphoma, B-Cell / diagnostic imaging
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Middle Aged
  • Positron-Emission Tomography
  • Recurrence
  • Remission Induction
  • Treatment Failure
  • Valproic Acid / therapeutic use*

Substances

  • Antineoplastic Agents
  • Fluorodeoxyglucose F18
  • Valproic Acid